Firm details
This firm has not yet provided any supplementary information. Please contact us for firm profiling options.
Key statistics
- Ranked Practice Areas
- 14
- Awards Won
- 12
- Recognised Lawyers
- 21
- Male:Female Ratio of Recognised Lawyers
- 19:2
Rankings
within China
Practice Area Subcategory | Index Rank | Ave. Tier | Table | ||
---|---|---|---|---|---|
Banking and finance | |||||
General | 7 | 2.8 | View full ranking table | ||
Capital markets | |||||
Debt | 2 | 2.0 | View full ranking table | ||
Equity | 2 | 2.0 | View full ranking table | ||
General | 7 | 2.3 | View full ranking table | ||
Structured finance, derivatives and securitisation | 4 | 2.0 | View full ranking table | ||
Construction | |||||
Disputes | 3 | 3.0 | View full ranking table | ||
General | 7 | Notable | View full ranking table | ||
Corporate and M&A | |||||
General | 6 | 2.5 | View full ranking table | ||
Dispute resolution | |||||
Arbitration | 8 | Notable | View full ranking table | ||
General | 10 | 3.0 | View full ranking table | ||
Insurance | |||||
General | 9 | Notable | View full ranking table | ||
Intellectual property | |||||
Disputes | 9 | 4.0 | View full ranking table | ||
General | 16 | 3.0 | View full ranking table | ||
International trade and WTO | |||||
General | 4 | 2.0 | View full ranking table | ||
Investment funds | |||||
General | 11 | 3.3 | View full ranking table | ||
Labour and employment | |||||
General | 11 | 3.0 | View full ranking table | ||
Private equity | |||||
General | 11 | 3.0 | View full ranking table | ||
Real estate | |||||
General | 10 | 3.5 | View full ranking table | ||
Restructuring and insolvency | |||||
General | 4 | 2.0 | View full ranking table | ||
Tax | |||||
General | 4 | 2.0 | View full ranking table |
Deals/Case awards
Total win-to-nominations ratio
1:7
Award | Ratio |
---|---|
Capital markets - Equity | |
Bestechnic Science and Technology Innovation Board IPO | 0:1 |
China Merchants Securities A+H shares rights issue | 0:1 |
SMIC STAR Market listing | 1:3 |
Corporate and M&A | |
China Resources Pharmaceutical / Boya Bio-pharmaceutical acquisition | 0:1 |
Restructuring and insolvency | |
Shanghai Huaxin Group wind-down | 0:1 |
Firm awards
Total win-to-nominations ratio
11:26
Award | Ratio |
---|---|
National awards | |
Antitrust and competition | 0:1 |
Banking and finance | 0:2 |
Capital markets | 0:1 |
Capital markets - Structured finance, derivatives and securitisation | 1:1 |
Construction | 1:1 |
Corporate and M&A | 1:1 |
Dispute resolution | 1:3 |
Dispute resolution - Arbitration | 0:1 |
Firm of the year | 1:2 |
Healthcare and life sciences | 0:1 |
Intellectual property - Copyright | 1:1 |
International trade and WTO | 1:2 |
Private client and wealth management | 1:1 |
Private equity | 0:1 |
Real estate | 0:2 |
Shipping | 1:2 |
Tax | 1:1 |
Transactions | 0:1 |
Practice management | |
Client service firm of the year | 1:1 |
Recognised lawyers
All data gathered from 2021 datasets. Learn more.